Hepatitis C virus core protein selectively inhibits synthesis and accumulation of p21/Waf1 and certain nuclear proteins

Microbiology and Immunology

Volumn 47, Issue 6, 2003, Pages 429-438

  Oka, Kiyomasa ^a,b   Nagano Fujii, Motoko ^a   Yoshida, Isao ^a   Hidajat, Rachmat ^a   Deng, Lin ^a   Akutsu, Masato ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Core protein; Hepatitis C virus; p21 Waf1; Translation inhibition

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CELL PROTEIN; CORE PROTEIN; CYCLINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MUTANT PROTEIN; NUCLEAR PROTEIN; PROTEIN C FOS; PROTEIN P21; PROTEIN P53; RIBONUCLEASE; RIBONUCLEASE L; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE EXPRESSION SYSTEM; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; TRANSLATION REGULATION; VIRUS CELL INTERACTION;

HEPATITIS C VIRUS; RNA VIRUSES; VACCINIA VIRUS;

EID: 0037971371     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03380.x     Document Type: Article

References (59)

1. Aoki, H., Hayashi, J., Moriyama, M., Arakawa, Y., and Hino, O. 2000. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74: 1736-1741.
2. Apichartpiyakul, C., Chittivudikarn, C., Miyajima, H., Homma, M., and Hotta, H. 1994. Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. J. Clin. Microbiol. 32: 2276-2279.
3. Bays, N.W., Gardner, R.G., Seelig, L.P., Joazeiro, C.A., and Hampton, R.Y. 2001. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat. Cell Biol. 3: 24-29.
4. Benedetti, C., Fabbri, M., Sitia, R., and Cabibbo, A. 2000. Aspects of gene regulation during the UPR in human cells. Biochem. Biophys. Res. Commun. 278: 530-536.
5. Blagosklonny, M.V., Wu, G.S., Omura, S., and El-Deiry, W.S. 1996. Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227: 564-569.
6. Chang, J., Yang, S.-H., Cho, Y.-G., Hwang, S.B., Hahn, Y.S., and Sung, Y.C. 1998. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol. 72: 3060-3065.
7. Doi, H., Apichartpiyakul, C., Ohba, K., Mizokami, M., and Hotta, H. 1996. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J. Clin. Microbiol. 34: 569-574.
8. Enomoto, N., Sakuma, I., Asahina, Y., Kurosaki, M., Murakami, T., Yamamoto, C., Ogura, Y., Izumi, N., Marumo, F., and Sato, C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334: 77-81.
9. Florese, R., Nagano-Fujii, M., Iwanaga, Y., Hidajat, R., and Hotta, H. 2002. Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus. Virus Res. 90: 119-131.
10. Fukuda, K., Morioka, H., Imajou, S., Ikeda, S., Ohtsuka, E., and Tsurimoto, T. 1995. Structure-function relationship of the eukaryotic DNA replication factor, proliferating cell nuclear antigen. J. Biol. Chem. 270: 22527-22534.
11. Gong, F., and Yanofsky, C. 2002. Instruction of translating ribosome by nascent peptide. Science 297: 1864-1867.
12. Harding, H.P., Zhang, Y., Bertolotti, A., Zeng, H., and Ron, D. 2000. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5: 897-904.
13. Harding, H.P., Zhang, Y., and Ron, D. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397: 271-274.
14. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M., and Shimotohno, K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. U.S.A. 88: 5547-5551.
15. Honda, M., Kaneko, S., Shimazaki, T., Matsushita, E., Kobayashi, K., Ping, L.-H., Zhang, H.-C., and Lemon, S.M. 2000. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 31: 1351-1359.
16. Hope, R.G., and McLauchlan, J. 2000. Sequence motifs required for hpid droplet association and protein stability are unique to the hepatitis C virus core protein. J. Gen. Virol. 81: 1913-1925.
17. Ichii, Y., Fukunaga, R., Shiojiri, S., and Sokawa, Y. 1986. Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14: 10117.
18. Ishido, S., and Hotta, H. 1998. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett. 438: 258-262.
19. Ishido, S., Fujita, T., and Hotta, H. 1998. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244: 35-40.
20. Ishido, S., Muramatsu, S., Fujita, T., Iwanaga, Y., Tong, W.-Y., Katayama, Y., Itoh, M., and Hotta, H. 1997. Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 230: 431-436.
21. Iwawaki, T., Hosoda, A., Okuda, T., Kamigori, Y., Nomura-Furuwatari, C., Kimata, Y., Tsuru, A., and Kohno, K. 2001. Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. Nat. Cell Biol. 3: 158-164.
22. Kuroki, Y., Shiozawa, S., Yoshihara, R., and Hotta, H. 1993. The contribution of human c-fos DNA to cultured synovial cells: a transfection study. J. Rheumatol. 20: 422-428.
23. Lauer, G.M., and Walker, B.D. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345: 41-52.
24. Liu, Q., Tackney, C., Bhat, R.A., Prince, A.M., and Zhang, P. 1997. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J. Virol. 71: 657-662.
25. Lu, W., Lo, S.-Y., Chen, M., Wu, K.-J., Fung, Y.K.T., and Ou, J.-H. 1999. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264: 134-141.
26. Maki, C.G., and Howley, P.M. 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17: 355-363.
27. Mamiya, N., and Worman, H.J. 1999. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274: 15751-15756.
28. Marusawa, H., Hijikata, M., Chiba, T., and Shimotohno, K. 1999. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation. J. Virol. 73: 4713-4720.
29. Mellor, J., Holmes, E.C., Jarvis, L.M., Yap, P.L., Simmonds, P., and The International HCV Collaborative Study Group. 1995. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J. Gen. Virol. 76: 2493-2507.
30. Mori, K. 2000. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101: 451-454.
31. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4: 1065-1067.
32. Muramatsu, S., Ishido, S., Fujita, T., Itoh, M., and Hotta, H. 1997. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J. Virol. 71: 4954-4961.
33. Ogata, S., Ku, Y., Yoon, S., Makino, S., Nagano-Fujii, M., and Hotta, H. 2002. Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma. Microbiol. Immunol. 46: 549-554.
34. Okazaki, K., and Sagata, N. 1995. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14: 5048-5059.
35. Otsuka, M., Kato, N., Lan, K.-H., Yoshida, H., Kato, J., Goto, T., Shiratori, Y., and Omata, M. 2000. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 275: 34122-34130.
36. Ray, R.B., Lagging, L.M., Meyer, K., Steele, R., and Ray, R. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37: 209-220.
37. Ray, R.B., Meyer, K., and Ray, R. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226: 176-182.
38. Ray, R.B., Meyer, K., Steele, R., Shrivastava, A., Aggarwal, B.B., and Ray, R. 1998. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273: 2256-2259.
39. Ray, R.B., Steele, R., Meyer, K., and Ray, R. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272: 10983-10986.
40. Ray, R.B., Steele, R., Meyer, K., and Ray, R. 1998. Hepatitis C virus core protein represses p21WAF1/Cip1/Sdi1 promoter activity. Gene 208: 331-336.
41. Reed, K.E., and Rice, C.M. 2000. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242: 55-84.
42. Rivas, C., Gil, J., Melková, Z., Esteban, M., and Díaz-Guerra, M. 1998. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 243: 406-414.
43. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M., Nainan, O., Netesov, S., Nishioka, K., Shin-i., T., Simmonds, P., Smith, D., Stuyver, L., and Weiner, A. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standardization. Arch. Virol. 143: 2493-2503.
44. Ruggieri, A., Harada, T., Matsuura, Y., and Miyamura, T. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229: 68-76.
45. Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Brechot, C., and Barba, G. 1999. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30: 1064-1076.
46. Shi, Y.Z., Hui, A.M., Takayama, T., Li, X., Cui, X., and Makuuchi, M. 2000. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Brit. J. Cancer 83: 50-55.
47. Shih, C.-M., Chen, C.-M., Chen, S.-Y., and Lee, Y.-H.W. 1995. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69: 1160-1171.
48. Shrivastava, A., Manna, S.K., Ray, R., and Aggarwal, B.B. 1998. Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72: 9722-9728.
49. Soetjipto, Handajani, R., Lusida, M.I., Darmadi, S., Adi, P., Soemarto, Ishido, S., Katayama, Y., and Hotta, H. 1996. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J. Clin. Microbiol. 34: 2875-2880.
50. Song, J., Fujii, M., Wang, F., Itoh, M., and Hotta, H. 1999. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. Gen. Virol. 80: 879-886.
51. Tai, D.-I., Tsai, S.-L., Chen, Y.-M., Chuang, Y.-L., Peng, C.-Y., Sheen, I.-S., Yeh, C.-T., Chang, K.S.S., Huang, S.-N., Kuo, G.C., and Liaw, Y.-F. 2000. Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31: 656-664.
52. Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman, J.S., and Walter, P. 2000. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101: 249-258.
53. Tsuchihara, K., Hijikata, M., Fukuda, K., Kuroki, T., Yamamoto, N., and Shimotohno, K. 1999. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology 258: 100-107.
54. Wang, F., Yoshida, I., Takamatsu, M., Ishido, S., Fujita, T., Oka, K., and Hotta, H. 2000. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdil1. Biochem. Biophys. Res. Commun. 273: 479-484.
55. Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S.-I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J.R., and Kohara, M. 1998. The native form and maturation process of hepatitis C virus core protein. J. Virol. 72: 6048-6055.
56. Yoshida, I., Oka, K., Hidajat, R., Nagano-Fujii, M., Ishido, S., and Hotta, H. 2001. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol. Immunol. 45: 689-697.
57. You, L.-R., Chen, C.-M., and Lee, Y.-H.W. 1999. Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor alpha. J. Virol. 73: 1672-1681.
58. Zhou, A., Hassel, B.A., and Silverman, R.H. 1993. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72: 753-765.
59. Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., and Lai, M.M.C. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72: 3691-3697.